Literature DB >> 22325712

Optimized light therapy for non-seasonal major depressive disorder: effects of timing and season.

Sara Dallaspezia1, Francesco Benedetti, Cristina Colombo, Barbara Barbini, Mara Cigala Fulgosi, Chiara Gavinelli, Enrico Smeraldi.   

Abstract

BACKGROUND: Light Therapy (LT) when combined with standard antidepressant treatment for unipolar depression hastens recovery. We studied the influence of LT timing on the antidepressant efficacy of LT and the influence of the season of treatment and recurrence on the response to treatment.
METHODS: We studied 70 inpatients affected by Unipolar Depression, treated for three weeks with combined LT and venlafaxine. Two-third of the patients received LT following a predictive algorithm based on MEQ scores; the others received LT at 11:00 a.m. Severity of depression was rated on the Hamilton Depression Rating Scale (HDRS). A subgroup of patients wore activity monitors.
RESULTS: HDRS scores significantly decreased during treatment (Friedman's ANOVA: χ2=186.82, p<0.00001). LT administered in the early morning showed a better relative efficacy than late morning (F=4.576; p=0.012) with the clinical improvement correlating with an advance in rest-activity rhythm acrophase (r=-0.336; p=0.017). Season of hospitalization interacted with LT timing and time in influencing response to treatment (F=3.101; p=0.049) and season of episode recurrence significantly interacted with LT timing, season of hospitalization and time (F=5.925; p=0.0035). LIMITATIONS: The major limitation of the study is the small sample size when considering simultaneously LT schedules, season of treatment and recurrence. Moreover, even if none of the patients fulfilled DSM-IV criteria for seasonal pattern of recurrence, they were not administered any questionnaire about seasonality.
CONCLUSIONS: We confirmed the usefulness of LT as a non-pharmacological antidepressant therapy for non-seasonal depression. Season and timing of administration and timing of the rest-activity cycle affected response to treatment.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22325712     DOI: 10.1016/j.jad.2012.01.019

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  6 in total

1.  Antepartum depression severity is increased during seasonally longer nights: relationship to melatonin and cortisol timing and quantity.

Authors:  Charles J Meliska; Luis F Martínez; Ana M López; Diane L Sorenson; Sara Nowakowski; Daniel F Kripke; Jeffrey Elliott; Barbara L Parry
Journal:  Chronobiol Int       Date:  2013-09-03       Impact factor: 2.877

Review 2.  Circadian entrainment and its role in depression: a mechanistic review.

Authors:  G S Lall; L A Atkinson; S A Corlett; P J Broadbridge; D R Bonsall
Journal:  J Neural Transm (Vienna)       Date:  2012-07-14       Impact factor: 3.575

3.  Augmentation of light therapy in difficult-to-treat depressed patients: an open-label trial in both unipolar and bipolar patients.

Authors:  Giovanni Camardese; Beniamino Leone; Riccardo Serrani; Coco Walstra; Marco Di Nicola; Giacomo Della Marca; Pietro Bria; Luigi Janiri
Journal:  Neuropsychiatr Dis Treat       Date:  2015-09-09       Impact factor: 2.570

4.  Effect of short-term colored-light exposure on cerebral hemodynamics and oxygenation, and systemic physiological activity.

Authors:  Felix Scholkmann; Timo Hafner; Andreas Jaakko Metz; Martin Wolf; Ursula Wolf
Journal:  Neurophotonics       Date:  2017-11-20       Impact factor: 3.593

5.  Shedding light on light exposure in elderly with intellectual disabilities.

Authors:  M N Böhmer; M J Valstar; M P J Aarts; P J E Bindels; A Oppewal; E J W van Someren; D A M Festen
Journal:  J Intellect Disabil Res       Date:  2021-02-16

Review 6.  Antidepressant chronotherapeutics for bipolar depression.

Authors:  Francesco Benedetti
Journal:  Dialogues Clin Neurosci       Date:  2012-12       Impact factor: 5.986

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.